Back to MRSA Staph Infection News List

The Time Is Right For Trials Of Multidrug Resistant TB Therapy

Drug-resistant TB strains may account for 10% of the 8 million new cases of TB that occur each year, say Carole Mitnick (Harvard Medical School, Boston, USA) and colleagues. Increasing concern about resistance has redoubled interest in strategies to control drug-resistant TB, they say, especially in settings of high HIV prevalence. Current treatments for MDR-TB last between 18 and 24 months, adverse effects are common, and many patients cannot be cured. [click link for full article]

Source: http://www.medicalnewstoday.com/sections/mrsa-superbug/

In addition to healthcare associated infections, MRSA can also infect people in the community at large, generally as skin infections that look like pimples or boils and can be swollen, painful and have draining pus. These skin infections often occur in otherwise healthy people.